Sustained clinical and histopathological remission in a patient with eosinophilic esophagitis and type 2 comorbidities after 18 months of discontinuation of dupilumab

Date

2023

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Eosinophilic esophagitis, Dupilumab, Discontinuation, Medicine, Gastroenterology, Internal medicine, Dermatology, Esophagitis, Eosinophilia

Citation

DOI

10.22541/au.168804227.77031880/v1

URI

https://doi.org/10.22541/au.168804227.77031880/v1
 https://andeanlibrary.org/handle/123456789/84191

Collections

Artículo Científico (Preprint)